# Buda Juice, Inc.: financial statements, quarterly

BUDA · NYSE · CIK 2079720 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/buda.md) · [Financials](/companies/buda/financials.md) · [Filings](/companies/buda/filings.md) · [Insiders](/companies/buda/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/buda/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,980](/filings/0001493152-26-023043.md) | [3,567](/filings/0001493152-26-038347.md) | [3,508](/filings/0001493152-26-023043.md) | [4,508](/filings/0001493152-26-038347.md) |
| Cost of revenue | $k | [1,642](/filings/0001493152-26-023043.md) | [1,900](/filings/0001493152-26-038347.md) | [2,122](/filings/0001493152-26-023043.md) | [2,857](/filings/0001493152-26-038347.md) |
| Gross profit | $k | [1,338](/filings/0001493152-26-023043.md) | [1,667](/filings/0001493152-26-038347.md) | [1,386](/filings/0001493152-26-023043.md) | [1,651](/filings/0001493152-26-038347.md) |
| Selling, general and administrative | $k | [407](/filings/0001493152-26-023043.md) | [378](/filings/0001493152-26-038347.md) | [663](/filings/0001493152-26-023043.md) | [1,055](/filings/0001493152-26-038347.md) |
| Operating income | $k | [803](/filings/0001493152-26-023043.md) | [1,144](/filings/0001493152-26-038347.md) | [593](/filings/0001493152-26-023043.md) | [444](/filings/0001493152-26-038347.md) |
| Income tax | $k | [9.0](/filings/0001493152-26-023043.md) | [9.0](/filings/0001493152-26-038347.md) | [359](/filings/0001493152-26-023043.md) | [129](/filings/0001493152-26-038347.md) |
| Net income | $k | [807](/filings/0001493152-26-038347.md) | [1,170](/filings/0001493152-26-038347.md) | [388](/filings/0001493152-26-038347.md) | [470](/filings/0001493152-26-038347.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.03](/filings/0001493152-26-023043.md) | [0.04](/filings/0001493152-26-038347.md) |
| Basic EPS | $ per share | not reported | not reported | [0.03](/filings/0001493152-26-023043.md) | [0.04](/filings/0001493152-26-038347.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [1.9](/filings/0001493152-26-012988.md) | not reported | not reported | [1.8](/filings/0001493152-26-023043.md) | [19.8](/filings/0001493152-26-023043.md) | not reported |
| Current assets | $m | not reported | [2.7](/filings/0001493152-26-012988.md) | not reported | not reported | [3.2](/filings/0001493152-26-038347.md) | [21.0](/filings/0001493152-26-023043.md) | [21.6](/filings/0001493152-26-038347.md) |
| Total assets | $m | not reported | [3.7](/filings/0001493152-26-012988.md) | not reported | not reported | [5.0](/filings/0001493152-26-038347.md) | [22.9](/filings/0001493152-26-023043.md) | [23.8](/filings/0001493152-26-038347.md) |
| Current liabilities | $m | not reported | [0.6](/filings/0001493152-26-012988.md) | not reported | not reported | [0.6](/filings/0001493152-26-038347.md) | [1.0](/filings/0001493152-26-023043.md) | [1.4](/filings/0001493152-26-038347.md) |
| Total liabilities | $m | not reported | [0.6](/filings/0001493152-26-012988.md) | not reported | not reported | [1.2](/filings/0001493152-26-038347.md) | [1.8](/filings/0001493152-26-023043.md) | [2.2](/filings/0001493152-26-038347.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.6](/filings/0001493152-26-038347.md) | [0.8](/filings/0001493152-26-023043.md) | [0.8](/filings/0001493152-26-038347.md) |
| Shareholders' equity | $m | [0.4](/filings/0001493152-26-012988.md) | [3.2](/filings/0001493152-26-038347.md) | [2.5](/filings/0001493152-26-038347.md) | [3.4](/filings/0001493152-26-038347.md) | [3.7](/filings/0001493152-26-038347.md) | [21.0](/filings/0001493152-26-038347.md) | [21.6](/filings/0001493152-26-038347.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [904](/filings/0001493152-26-023043.md) | [929 d](/filings/0001493152-26-038347.md) | [1,305](/filings/0001493152-26-023043.md) | [(365) d](/filings/0001493152-26-038347.md) |
| Capital expenditure | $k | [139](/filings/0001493152-26-023043.md) | not reported | [218](/filings/0001493152-26-023043.md) | [(118) d](/filings/0001493152-26-038347.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001493152-26-023043.md) | [12.9](/filings/0001493152-26-038347.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,566,666 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038347.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.